{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:40:35Z","timestamp":1720111235622},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/mt.2015.107","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T21:01:29Z","timestamp":1433970089000},"page":"1663-1670","source":"Crossref","is-referenced-by-count":4,"title":["Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Guohua","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongying","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Bharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premlata","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.107_bib1","doi-asserted-by":"crossref","first-page":"1232910","DOI":"10.1126\/science.1232910","article-title":"Accelerating next-generation vaccine development for global disease prevention","volume":"340","author":"Koff","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2015.107_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.107_bib3","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.vaccine.2011.11.014","article-title":"HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem","volume":"30","author":"Koff","year":"2012","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.107_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1038\/mt.2015.107_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2015.107_bib6","doi-asserted-by":"crossref","first-page":"17880","DOI":"10.1073\/pnas.1004728107","article-title":"Elicitation of structure-specific antibodies by epitope scaffolds","volume":"107","author":"Ofek","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.107_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.str.2010.06.010","article-title":"Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope","volume":"18","author":"Correia","year":"2010","journal-title":"Structure"},{"key":"10.1038\/mt.2015.107_bib8","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope","volume":"78","author":"Ofek","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib9","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"Zwick","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib10","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib11","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.00184-09","article-title":"Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope","volume":"83","author":"Arnold","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib12","doi-asserted-by":"crossref","first-page":"e72205","DOI":"10.1371\/journal.pone.0072205","article-title":"Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses","volume":"8","author":"Yi","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.107_bib13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/eji.1830230623","article-title":"Antigen processing and presentation of human rhinovirus to CD4 T cells is facilitated by binding to cellular receptors for virus","volume":"23","author":"Hastings","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2015.107_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JVI.72.1.651-659.1998","article-title":"Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1","volume":"72","author":"Smith","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nm1713","article-title":"Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation","volume":"14","author":"Bartlett","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.107_bib16","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.107_bib17","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1128\/JVI.02864-12","article-title":"Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates","volume":"87","author":"Richardson","year":"2013","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.vaccine.2009.10.028","article-title":"Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection","volume":"28","author":"Sellhorn","year":"2009","journal-title":"Vaccine"},{"key":"10.1038\/mt.2015.107_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41","volume":"22","author":"Cardoso","year":"2005","journal-title":"Immunity"},{"key":"10.1038\/mt.2015.107_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1084\/jem.20121977","article-title":"Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies","volume":"210","author":"Yang","year":"2013","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2015.107_bib21","doi-asserted-by":"crossref","first-page":"e1003639","DOI":"10.1371\/journal.ppat.1003639","article-title":"Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10","volume":"9","author":"Finton","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2015.107_bib22","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.1301285","article-title":"Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10","volume":"191","author":"Doyle-Cooper","year":"2013","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.107_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/QAD.0b013e32834785cf","article-title":"Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies","volume":"25","author":"Singh","year":"2011","journal-title":"AIDS"},{"key":"10.1038\/mt.2015.107_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11427-013-4591-0","article-title":"10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime","volume":"57","author":"Yu","year":"2014","journal-title":"Sci China Life Sci"},{"key":"10.1038\/mt.2015.107_bib25","doi-asserted-by":"crossref","first-page":"S1032","DOI":"10.1093\/infdis\/jir332","article-title":"Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs","volume":"204 Suppl 3","author":"Richardson","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2015.107_bib26","doi-asserted-by":"crossref","first-page":"12676","DOI":"10.1128\/JVI.01893-12","article-title":"Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus","volume":"86","author":"Sather","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.107_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"10.1038\/mt.2015.107_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"10.1038\/mt.2015.107_bib29","doi-asserted-by":"crossref","first-page":"e10254","DOI":"10.1371\/journal.pone.0010254","article-title":"Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes","volume":"5","author":"Hioe","year":"2010","journal-title":"PLoS One"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T06:19:32Z","timestamp":1599113972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616302970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1525001616302970"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.107","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}